Table 2.
Demographics
| Placebo N=72 |
Treatment N=72 |
Total N=144 |
p value | |
|---|---|---|---|---|
|
| ||||
| Gender | ||||
| M | 42 | 39 | 81 | Reference |
| F | 30 | 33 | 63 | 0.61 |
|
| ||||
| Weight (kilograms) | ||||
| Median (IQR) | 5.7 (4.2–14.0) | 5.8 (4.0–10.7) | 0.46a | |
|
| ||||
| Race | ||||
| Latino | 20 | 26 | 46 | Reference |
| Asian | 11 | 7 | 18 | 0.21 |
| Black | 2 | 2 | 4 | 0.80 |
| White | 37 | 35 | 72 | 0.40 |
| Other/Unknown | 2 | 2 | 4 | 0.86 |
|
| ||||
| Preop Inpatient | 24 | 27 | 51 | 0.6 |
|
| ||||
| Preop Inotrope Use | 2 | 5 | 7 | 0.23 |
|
| ||||
| Preop Intubation | 7 | 7 | 14 | 1.0 |
|
| ||||
| Age at surgery (days) | ||||
| Median (IQR) | 165 (58–1332) | 154 (64–656) | 0.59a | |
|
| ||||
| Prior Cardiac Surgery | ||||
| Yes | 18 | 32 | 50 | Reference |
| No | 54 | 40 | 94 | 0.02 |
|
| ||||
| RACHS-1 score | ||||
| 1 | 0 | 1 | 1 | |
| 2 | 17 | 20 | 37 | Reference |
| 3 | 29 | 25 | 54 | 0.40 |
| 4 | 23 | 25 | 48 | 0.77 |
| 5 | 3 | 1 | 4 | 0.28 |
|
| ||||
| Single Ventricle (n) | 3 | 6 | 9 | 0.3 |
|
| ||||
| CPB time (min) | 153 (93–220) | 133 (84–201) | 0.22a | |
|
| ||||
| Cross-clamp time (min) | 45 (30–96) | 52 (29–83) | 0.44a | |
|
| ||||
| Age at CVICU admit (days) Median (IQR) | 165 (58–1333) | 154 (50–656) | 0.57a | |
|
| ||||
| Chest Open | ||||
| No | 62 | 59 | 121 | Reference |
| Yes | 10 | 13 | 23 | 0.50 |
a
Mann-Whitney-Wilcoxon Test
IQR: interquartile range; RACHS-1: Risk Adjusted Congenital Heart Surgery-1; CPB: cardiopulmonary bypass; CVICU: cardiovascular intensive care unit.